Calif. Prop 61 Raises Industry Concerns Over Ripple Effect

Industry executives are speaking out against the measure that would require California state agencies to pay no more than the US Department of Veterans Affairs pay for drugs.

Bottles

More from Pricing Debate

More from Market Access